Phenibut Powder

£70,500.00

Phenibut Powder is a fine crystalline industrial-grade neurochemical compound used primarily in research and controlled formulation environments. It is valued for its role as a GABA-derivative intermediate in laboratory and pharmaceutical R&D applications. The product offers high consistency, stable composition, and reliable batch uniformity for precision use cases. It is strategically important in niche chemical research markets due to its reproducibility and controlled synthesis profile.

2. Competitive Advantage Spotlight
Manufactured under strict quality control with consistent particle uniformity, Phenibut Powder ensures dependable performance in research and formulation workflows. Its stable chemical profile and scalable supply chain support uninterrupted procurement for institutional and industrial buyers.

Description

1. Product Overview

Phenibut Powder is a specialized neuroactive phenyl derivative of GABA, utilized primarily as a pharmaceutical intermediate and research compound in CNS (central nervous system) studies. Its key value proposition is exceptional batch-to-batch purity consistency (≥99.0%), enabling reproducible experimental outcomes. Strategically, it occupies a critical niche in the development of anxiolytic and nootropic analogs, making supply reliability a competitive differentiator for industrial R&D procurement.


2. Key Specifications & Technical Characteristics

  • Chemical composition: β-Phenyl-γ-aminobutyric acid hydrochloride (C₁₀H₁₃NO₂·HCl)

  • Purity level: ≥99.0% (HPLC), pharmaceutical intermediate grade

  • Physical characteristics: Fine, white to off-white crystalline powder; free-flowing; particle size D90 ≤ 150 µm; bulk density 0.45–0.65 g/cm³

  • Packaging options: 25 kg fiber drums with double LDPE liners; 500 g–5 kg lab-sample HDPE containers available

  • Shelf life: 36 months in unopened, dry, room-temperature (15–25°C) storage


3. Core Industrial Applications

  • Pharmaceutical R&D intermediates: Used in proprietary synthesis of GABAergic analogues—outperforms generic GABA due to enhanced lipophilicity and blood-brain barrier penetration in test models.

  • Analytical reference standard manufacturing: Serves as a high-purity calibration material for QC labs; consistent crystallinity reduces retention time drift compared to lower-grade sources.

  • Biotechnology screening platforms: Enables high-throughput assays for receptor binding studies (GABAₐ, GABAß); cost advantage through reduced retesting from batch variability.


4. Competitive Advantages

  • Quality consistency: Every batch HPLC-tested and COA-available with residual solvent analysis (meets ICH Q3D limits).

  • Supply reliability: 20 MT monthly production capacity with safety stock held in three regional distribution hubs (Asia, EU, NA).

  • Logistics capability: Temperature-controlled dry van or air-freight packaging for expedited 5–7 day door-to-door delivery.

  • Price competitiveness: Tiered pricing from 1 MT to 20 MT, benchmarked against European and Asian generic intermediates.

  • Technical support: Full impurity profile, NMR, and FTIR spectra provided; direct QC team access for specification alignment.


5. Commercial & Supply Information

  • Minimum order quantity (MOQ): 20 kg (R&D grade); 1 MT (industrial batch)

  • BULK 20MT: Yes – single lot homogeneity guaranteed

  • Loading capacity: 12 MT per standard 20-ft dry container (palletized, 600 kg/m³ load density)

Reviews

There are no reviews yet.

Be the first to review “Phenibut Powder”

Your email address will not be published. Required fields are marked *

Add to cart